Skip to content

Isomorphic Labs

Isomorphic Labs provides an AI‑driven drug design platform for pharmaceutical and biotech researchers.

Isomorphic Labs is a biotech & life sciences company based in GB, founded in 2021. It has raised $5 billion in disclosed funding. Its latest round was a Series C of $5 billion in November 2026.

Overview

Isomorphic Labs operates an AI‑powered drug design engine called IsoDDE that combines predictive and generative models to navigate vast chemical space and evaluate molecule properties. The platform is used by pharmaceutical and biotechnology researchers to accelerate discovery of new medicines across modalities such as small molecules, antibodies and gene therapies. By integrating deep learning with experimental data, IsoDDE helps teams generate candidate structures, predict efficacy and safety, and reduce the time spent on synthesis and testing. The company was founded in 2021 by Demis Hassabis, former DeepMind CEO, and positions its technology as a systematic way to discover and design medicines for many diseases. To date Isomorphic Labs has raised a total of $5 billion and is classified as a series‑C‑plus venture, indicating a mature financing stage. Its team blends AI researchers, chemists and biologists who work side‑by‑side to translate computational insights into drug programs that are moving toward clinical trials.

AI drug discoverygenerative chemistrypredictive modelingpharma AI platformdeep learning biotechmolecule designdrug developmentclinical translation

Funding

Total disclosed: $5B across 1 round. Computed only from sourced rounds.

  • Nov 17 · Series C

    Led by Greenoaks, Sequoia Capital · with Andreessen Horowitz, +9

    Biotech & Life Sciences3 sources

Investors

Questions and answers

What does Isomorphic Labs do?

Isomorphic Labs provides an AI‑driven drug design platform for pharmaceutical and biotech researchers.

How much has Isomorphic Labs raised?

Isomorphic Labs has raised $5 billion in disclosed funding across 1 round tracked by OSH.

Who has invested in Isomorphic Labs?

Investors in Isomorphic Labs include Greenoaks, Sequoia Capital, Andreessen Horowitz, Thrive Capital, Alphabet and 7 more.

When and where was Isomorphic Labs founded?

Isomorphic Labs was founded in 2021 and is based in GB.

Timeline

  1. Nov 17, 2026

    Series C · $5B

  2. 2021

    Founded

Sources

  1. 1.Sequoia and Greenoaks lead massive $5BN Series C funding round in Isomorphic Labs — Tech.eu, Nov 17, 2026
  2. 2.Startup ecosystem calls to withdraw and re-table EU Inc proposal, Isomorphic Labs bags $5B, and inside Plural's €1B fund — Tech.eu, Nov 20, 2026
  3. 3.Isomorphic Labs raises $5 billion in Series C to push AI-designed drugs toward clinical trials — cryptobriefing.com, Nov 17, 2026
  4. 4.Isomorphic Labs · Official
  5. 5.Isomorphic Labs · Official

Verified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).Last verified Nov 21, 2026